Vanguard Group Inc Pliant Therapeutics, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,526,514 shares of PLRX stock, worth $49.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,526,514

Previous 3,437,160 2.6%

Holding current value

$49.4 Million

Previous $36.9 Million 6.99%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$10.52 - $14.35 $940,004 - $1.28 Million	89,354 Added 2.6%	3,526,514 $39.5 Million
Q2 2024 Aug 13, 2024	SELL	$10.58 - $15.61 $435,843 - $643,053	-41,195 Reduced 1.18%	3,437,160 $36.9 Million
Q1 2024 May 10, 2024	BUY	$14.14 - $19.59 $5.83 Million - $8.08 Million	412,486 Added 13.45%	3,478,355 $51.8 Million
Q4 2023 Feb 14, 2024	BUY	$12.85 - $19.15 $1.55 Million - $2.31 Million	120,557 Added 4.09%	3,065,869 $55.5 Million
Q3 2023 Nov 14, 2023	BUY	$14.58 - $20.15 $2.46 Million - $3.39 Million	168,454 Added 6.07%	2,945,312 $51.1 Million
Q2 2023 Aug 14, 2023	BUY	$18.12 - $30.56 $7.32 Million - $12.4 Million	404,136 Added 17.03%	2,776,858 $50.3 Million
Q1 2023 May 15, 2023	BUY	$18.73 - $36.26 $7.94 Million - $15.4 Million	423,678 Added 21.74%	2,372,722 $63.1 Million
Q4 2022 Feb 10, 2023	BUY	$17.0 - $25.43 $5.95 Million - $8.89 Million	349,720 Added 21.87%	1,949,044 $37.7 Million
Q3 2022 Nov 14, 2022	BUY	$7.67 - $24.23 $4.19 Million - $13.2 Million	546,638 Added 51.93%	1,599,324 $33.4 Million
Q2 2022 Aug 12, 2022	SELL	$4.11 - $8.75 $739,853 - $1.58 Million	-180,013 Reduced 14.6%	1,052,686 $8.43 Million
Q1 2022 May 13, 2022	BUY	$7.01 - $14.1 $100,165 - $201,474	14,289 Added 1.17%	1,232,699 $8.64 Million
Q4 2021 Feb 14, 2022	SELL	$12.27 - $18.26 $2.46 Million - $3.66 Million	-200,189 Reduced 14.11%	1,218,410 $16.4 Million
Q3 2021 Nov 12, 2021	BUY	$16.48 - $28.98 $2.42 Million - $4.26 Million	146,943 Added 11.56%	1,418,599 $23.9 Million
Q2 2021 Aug 13, 2021	BUY	$28.05 - $37.69 $35.7 Million - $47.9 Million	1,271,656 New	1,271,656 $37 Million

Others Institutions Holding PLRX

# of Institutions

168

Shares Held

63.2M

Call Options Held

245K

Put Options Held

373K

View Full List

About PLIANT THERAPEUTICS, INC.

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $682M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

More about PLRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Pliant Therapeutics, Inc. Transaction History